Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06671327

Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain

Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain After Noncardiac Surgery

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
208 (estimated)
Sponsor
China International Neuroscience Institution · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Background:Preemptive analgesia is the initiation of analgesic regimen before the onset of nociceptive stimulation, preventing the amplification of pain due to peripheral and central sensitization and thereby reducing subsequent pain. Preemptive analgesia of dexmedetomidine (DEX) in the epidural and subarachnoid space can effectively prevent the central sensitization, and significantly reduce the phantom limb pain, residual pain after one year of lower limb amputation. Objective: To investigate the per-operative effects of DEX preemptive analgesia. Method:The patients scheduled noncardiac surgery undergoing general anesthesia were selected and divided into DEX group and Placebo group randmized. The DEX group was continuously pumped at 1.5 μg /(kg·h) for 15 minutes before induction, and 15min after induction. The Placebo group was infused with equal amounts of normal saline.The Coprimary efficacy outcome was a composite of analgesia effect, one is the Compliance Rate of IOC2 target in intra-operation, another is the the rate of none-to-slight post-operative pain assessed with the p-NRS≦3 at 12 hours after surgery \[Pain numeric rating scale was assessed with the (Numeric Rating Scale, p-NRS)\].

Detailed description

Background:Preemptive analgesia is the initiation of analgesic regimen before the onset of nociceptive stimulation, preventing the amplification of pain due to peripheral and central sensitization and thereby reducing subsequent pain. Preemptive analgesia of DEX in the epidural and subarachnoid space can effectively prevent the central sensitization, and significantly reduce the phantom limb pain, residual pain after one year of lower limb amputation. Objective: To investigate the per-operative effects of DEX preemptive analgesia.

Conditions

Interventions

TypeNameDescription
DRUGPreemptive Dexmedetomidine injectionThe DEX group was continuously pumped at 1.5 μg /(kg·h) for 15 minutes before induction, and after induction continue infusion 15min.
DRUGSodium Chloride 0.9% InjThe Placebo group was infused with equal amounts of isochronous normal saline.

Timeline

Start date
2025-04-03
Primary completion
2025-06-23
Completion
2025-06-30
First posted
2024-11-04
Last updated
2025-04-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06671327. Inclusion in this directory is not an endorsement.